We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.25%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10B
AUM Growth
+$477M
Cap. Flow
+$229M
Cap. Flow %
2.28%
Top 10 Hldgs %
15.52%
Holding
1,590
New
33
Increased
385
Reduced
1,013
Closed
155

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$14.4M
2
VAL
Valspar
VAL
+$10M
3
MMM icon
3M
MMM
+$9.22M
4
GS icon
Goldman Sachs
GS
+$8.07M
5
MCD icon
McDonald's
MCD
+$8.07M

Sector Composition

Rank Sector Weight
1 Financials 15.02%
2 Healthcare 14.76%
3 Technology 13.2%
4 Consumer Staples 11.05%
5 Industrials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INN
1351
Summit Hotel Properties
INN
$761M
$198K ﹤0.01%
10,596
-1,546
-13% -$27K
PACB icon
1352
Pacific Biosciences
PACB
$429M
$197K ﹤0.01%
55,431
-3,263
-6% -$13.2K
CHS
1353
DELISTED
Chicos FAS, Inc.
CHS
$197K ﹤0.01%
20,905
-5,451
-21% -$63K
HRG
1354
DELISTED
HRG Group, Inc.
HRG
$189K ﹤0.01%
10,695
-3,292
-24% -$61.8K
UPL
1355
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$187K ﹤0.01%
+17,241
New +$195K
CLF icon
1356
Cleveland-Cliffs
CLF
$5.39B
$186K ﹤0.01%
26,920
-6,531
-20% -$43.3K
NERV icon
1357
Minerva Neurosciences
NERV
$206M
$186K ﹤0.01%
2,633
+37
+1% +$2.4K
CLDX icon
1358
Celldex Therapeutics
CLDX
$2.73B
$185K ﹤0.01%
4,994
-90
-2% -$3.98K
PETX
1359
DELISTED
Aratana Therapeutics, Inc.
PETX
$183K ﹤0.01%
25,322
+1,709
+7% +$10.5K
HL icon
1360
Hecla Mining
HL
$10.5B
$178K ﹤0.01%
34,833
-9,110
-21% -$50.5K
NE
1361
DELISTED
Noble Corporation
NE
$176K ﹤0.01%
48,685
+4,047
+9% +$18.6K
DO
1362
DELISTED
Diamond Offshore Drilling
DO
$176K ﹤0.01%
16,261
+4,665
+40% +$62K
ESI icon
1363
Element Solutions
ESI
$9.35B
$174K ﹤0.01%
13,729
-2,674
-16% -$35K
SEM
1364
DELISTED
Select Medical
SEM
$174K ﹤0.01%
21,064
-7,218
-26% -$54.2K
NGNE icon
1365
Neurogene
NGNE
$720M
$169K ﹤0.01%
601
-24
-4% -$6.87K
VIVS
1366
VivoSim Labs
VIVS
$1.61M
$164K ﹤0.01%
260
-19
-7% -$12.8K
MDXG icon
1367
MiMedx Group
MDXG
$621M
$160K ﹤0.01%
10,666
-3,432
-24% -$45.8K
BPFH
1368
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$160K ﹤0.01%
10,403
-2,813
-21% -$43.6K
JCP
1369
DELISTED
J.C. Penney Company, Inc.
JCP
$160K ﹤0.01%
34,488
+5,635
+20% +$28.8K
CRIS icon
1370
Curis
CRIS
$9.63M
$159K ﹤0.01%
42
-2
-5% -$8.36K
MWA icon
1371
Mueller Water Products
MWA
$3.89B
$159K ﹤0.01%
13,622
-4,326
-24% -$49.7K
CERS icon
1372
Cerus
CERS
$605M
$158K ﹤0.01%
62,937
-3,946
-6% -$12.6K
TIME
1373
DELISTED
Time Inc.
TIME
$158K ﹤0.01%
10,988
-9,898
-47% -$148K
WLL
1374
DELISTED
Whiting Petroleum Corporation
WLL
$156K ﹤0.01%
95
+2
+2% +$4.57K
OCLR
1375
DELISTED
Oclaro Inc.
OCLR
$154K ﹤0.01%
16,531
+3,650
+28% +$33K

Similar funds

ProShare Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, ProShare Advisors held 1,590 positions worth $10B, up 5% from $9.56B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

ProShare Advisors's Q2 2017 filing shows 33 new, 385 increased, 1,013 reduced and 155 closed positions. Its largest new stake was Westwood Holdings Group: 133,198 shares worth $7.55M. The largest sale was Yahoo Inc, an estimated $14.4M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.

  • ProShare Advisors's largest Q2 2017 buy was Westwood Holdings Group: 133,198 shares worth $7.55M.
  • ProShare Advisors added most to Apple in Q2 2017, an estimated $44.7M increase.
  • ProShare Advisors's biggest Q2 2017 reduction was 3M, cutting an estimated $9.22M.
  • ProShare Advisors fully exited Yahoo Inc in Q2 2017, selling an estimated $14.4M.
  • ProShare Advisors's ten largest holdings make up 16% of its $10B portfolio in Q2 2017.
  • ProShare Advisors opened 33 new positions and closed 155 in Q2 2017.
  • ProShare Advisors's portfolio value rose 5% quarter-over-quarter to $10B.

Based on ProShare Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.